As discussed in our previous update, Crunchfish has now settled on a path forward for the...
Read More →With the dust settling after the acquisition of Sydvaranger and the updated DFS for Dannemora in...
Read More →MODI reported Q2’24 sales largely in line with last year, at SEK 7.4m compared to SEK 7.6m in...
Read More →Supported by the latest troponin data generated from whole blood samples on the final commercial...
Read More →After initiating dosing of the first patient in June with Nanexa’s long-acting depot formulation...
Read More →While the commercialization of Crunchfish’s solution for offline payments has shown a longer...
Read More →In terms of financials, Q2 was largely a repeat of Q1, with one-off replanting and remediation...
Read More →The announcement of the updated DFS for Dannemora showed, as expected, higher CAPEX and OPEX...
Read More →